J. Milano

A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis

C. Guttmann, D. Bourdette, J. Bowen, 2005, Multiple sclerosis.

Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.

P. Richardson, D. Kufe, R. Joyce, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Therapeutic vaccination with a trivalent T‐cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis

D. Bourdette, A. Vandenbark, H. Offner, 2008, Immunology.